Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,168,026 papers from all fields of science
Search
Sign In
Create Free Account
TG101348
Known as:
SAR302503
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (1)
Fedratinib
Broader (3)
JAK2 Inhibitor TG101348
Pyrrolidines
Sulfonamides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Abstract 2435: Anticipating clinical resistance to SAR302503, a JAK2 inhibitor in clinical development for the treatment of myelofibrosis.
Raelene Hurley
,
R. Greco
,
+6 authors
F. Adrián
2013
Corpus ID: 72501862
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC One of the challenges of using kinase inhibitors in…
Expand
2013
2013
Exploring potential clinical resistance to SAR302503, a selective JAK2 inhibitor in clinical development for the treatment of myelofibrosis
Raelene Hurley
,
R. Greco
,
+6 authors
F. Adrián
2013
Corpus ID: 86164340
• One of the challenges faced when using kinase inhibitors in the clinic is the potential emergence of resistance mechanisms that…
Expand
2012
2012
Postępy w leczeniu samoistnego włóknienia szpiku Advances in the therapy of primary myelofibrosis
Tomasz Sacha
2012
Corpus ID: 74196801
Primary myelofibrosis (PMF) harbors the worst prognosis among the Philadelphia chromosome-negative chronic myeloproliferative…
Expand
2011
2011
Combination Targeted Therapy to Impair Self-Renewal Capacity of Human Blast Crisis Leukemia Stem Cells
Angela Court Recart
,
A. Sadarangani
,
+9 authors
C. Jamieson
2011
Corpus ID: 208461728
Abstract 1693 The aim of this study is to develop clinical strategies that will HALT progression of CML by reducing leukemia stem…
Expand